Pauza Charles David bought TRAW

March 8, 2026 · Form 4 insider transaction

Pauza Charles David bought 118,367 shares of Traws Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
118,367
Price
$0.00
Total value
N/A
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 8, 2026
Filing dateMarch 10, 2026
Shares owned after118,367
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.

View the original Form 4 on SEC EDGAR